Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study. - Suppr | 超能文献

Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study.

作者信息

Ujeyl Amaar, Fang James C, Desai Akshay S, Mudge Gilbert H, Givertz Michael M

出版信息

J Heart Lung Transplant. 2011 Oct;30(10):1200-1. doi: 10.1016/j.healun.2011.07.016.

DOI:10.1016/j.healun.2011.07.016

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study.

J Heart Lung Transplant. 2011 Oct;30(10):1200-1. doi: 10.1016/j.healun.2011.07.016.

2

Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial.维生素C和E对移植相关动脉硬化进展的影响：一项随机试验。

Lancet. 2002 Mar 30;359(9312):1108-13. doi: 10.1016/S0140-6736(02)08154-0.

3

Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E.冠状动脉内皮功能对心脏移植相关动脉硬化进展的影响：抗氧化维生素C和E的作用

J Heart Lung Transplant. 2006 Apr;25(4):426-33. doi: 10.1016/j.healun.2005.11.450.

4

Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients.

J Heart Lung Transplant. 2005 Aug;24(8):990-4. doi: 10.1016/j.healun.2004.06.001.

5

Cardiac allograft vasculopathy.心脏同种异体移植血管病。

Rev Cardiovasc Med. 2011;12(3):143-52.

6

Are neointimal smooth muscle cells in human cardiac allograft vasculopathy of donor origin?人类心脏移植血管病变中的新生内膜平滑肌细胞来源于供体吗？

J Heart Lung Transplant. 2005 Aug;24(8):1121-2. doi: 10.1016/j.healun.2004.07.019.

7

Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial.氟伐他汀预防肾移植血管病变：一项前瞻性、随机、双盲、安慰剂对照试验的结果

Transplantation. 2008 Jul 15;86(1):82-7. doi: 10.1097/TP.0b013e318174428d.

8

TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?雷帕霉素靶蛋白抑制剂与心脏移植血管病变：抑制内膜增厚是否足以作为获益的替代指标？

J Heart Lung Transplant. 2003 May;22(5):501-4. doi: 10.1016/s1053-2498(02)00525-9.

9

Preliminary results of a prospective randomized study of cyclosporine versus tacrolimus in the development of cardiac allograft vasculopathy at 1 year after heart transplantation.心脏移植术后1年时环孢素与他克莫司预防心脏移植血管病变的前瞻性随机研究初步结果

Transplant Proc. 2010 Oct;42(8):3199-200. doi: 10.1016/j.transproceed.2010.05.055.

10

Carotid intima media thickness and cardiac allograft vasculopathy after heart transplantation in childhood.

Transplantation. 2011 Mar 27;91(6):e46-7. doi: 10.1097/TP.0b013e31820ae4de.

引用本文的文献

1

Modernization of Chronic Allograft Injury Research: Better Biomarkers, Better Studies, Better Outcomes.慢性同种异体移植损伤研究的现代化：更好的生物标志物、更好的研究、更好的结果。

Clin Transpl. 2015;31:211-225.

2

Effects of vitamin C treatment on collar-induced intimal thickening.维生素C治疗对套环诱导内膜增厚的影响。

Drug Des Devel Ther. 2015 Dec 15;9:6461-73. doi: 10.2147/DDDT.S97020. eCollection 2015.